NEURYSMAL SAH carries a high risk of morbidity and death. The prognosis remains unsatisfactory, mainly because of severe initial bleeding, early rebleeding, and DID, all of which lead to impairment of cerebral blood flow. 7, 15 A high rate of hypodense lesions consistent with cerebral infarcts (40-60%) is apparent on CT at 3 months 5,10,13 and 1 year after SAH. 9,14 Although most of these lesions are small (median volume Ͻ 10 ml), 5 their identification is important given that their occurrence correlates highly with patient outcome. 5, 9, 13, 17 One half of all new ischemic lesions seen during the follow-up period were already visible on CT on the first postoperative day; 13 the other half develop during the next 2 weeks, mainly because of delayed ischemia.
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Our objective in the present study was to prospectively determine the effects of both the cause and time of development of ischemic lesions on outcome after SAH by using serial CT scanning. Magnetic resonance imaging was used to ascertain the quality of CT findings.
Clinical Material and Methods

Patient Population
The study population consisted of 156 patients younger than 76 years who were enrolled into a prospective, randomized, double-blind, placebo-controlled enoxaparin trial and whose follow-up CT scans were available. 13, 20 Enoxaparin had no effect on clinical outcome or the development of ischemic lesions as seen on CT. For detailed inclusion and exclusion criteria of the patients and for baseline characteristics and treatment methods, see our previous reports. 13, 20 Briefly, we excluded patients who had been admitted to our hospital more than 48 hours after bleeding or with an ICH greater Early ischemic lesion on computed tomography: predictor of poor outcome among survivors of aneurysmal subarachnoid hemorrhage than 20 mm in diameter. Computed tomography scans were routinely obtained on admission, on the first postoperative morning, and at discharge 10 to 12 days after SAH. Followup CT and MR imaging were performed during the outpatient department visit at 3 months after SAH.
Clinical Monitoring, Treatment, and Outcome
Each patient's clinical condition on admission and before surgery was scored according to the WFNS grading scale. 1 Neurological examinations were performed daily. Ruptured aneurysms were secured within a mean of 25 hours (median 22 hours, range 5-60 hours) after SAH by performing open surgery (151 patients), endovascular coil insertion (two patients), open surgery and coil insertion combined (two patients), or trapping of the aneurysm and the artery (one patient). Aneurysms were surgically treated by 12 neurosurgeons.
A deterioration in the level of consciousness or the gradual development of focal neurological signs was considered indicative of DID after ruling out other causes of the symptoms. Other reasons for a poor clinical condition were determined by performing repeated CT scanning, routine postoperative angiography, autopsy procedures, or laboratory investigations.
Mannitol was routinely used during all operations. Intravenous nimodipine treatment was started within a mean of 14 hours after the onset of SAH and continued until 10 to 12 days after bleeding. Thereafter, nimodipine was administered orally for up to 21 days after SAH. Hypertension, hypervolemia, or endovascular vasospasm therapy was not routine, although endovascular treatment was applied in three cases with ischemic symptoms.
Patients were examined in the outpatient department 3 months after SAH to assess outcome according to the GOS; 8, 13, 20 a poor outcome was defined as severe disability or worse. At that time, follow-up CT scans and MR images were obtained. All neuroimaging studies were evaluated together by experienced neuroradiologists (M.P. and K.P.) who were blinded to the case history of each patient. Computed tomography scans and MR images were analyzed separately, with CT reviewed first. For detailed data on the radiological findings, see our previous report. 13 
Statistical Analysis
Data were analyzed using SPSS for Windows, version 12.0.1.2003 (SPSS, Inc.). For univariate analysis, conventional statistical tests were applied. The association of continuous variables was tested with Spearman rank correlation coefficients (r s ). Univariate and multivariate ORs and 95% CIs of risk factors, including their interactions, for a poor outcome at 3 months after SAH were analyzed using unconditional logistic regression. A two-tailed probability value less than 0.05 was considered significant.
Results
Patient characteristics are provided in Table 1 . To reveal the effect of early as opposed to late ischemia on clinical outcome, we identified three groups of patients. The early ischemia group (52 patients) was comprised of patients with a new hypodense lesion on the first postoperative CT. Patients in the late ischemia group (51 patients) had a new hypodense lesion on CT at discharge (10-12 days after the operation) or on the 3-month follow-up CT but not on the first postoperative CT. These groups were compared with a reference group of 53 patients with no lesion on CT during treatment.
On the 3-month follow-up CT, 101 patients had an ischemic lesion that had not been visible on the admission CT. Of these 101 patients, 50 were in the early and 51 in the late ischemic lesion group. Although early lesions were visible in 52 patients, the hypodense lesion disappeared after the first postoperative day in two (Table 1) . Furthermore, 94 of the 101 patients with a lesion on follow-up CT already had a lesion 10 to 12 days after SAH. In only four patients (3%) did MR images reveal a lesion not visible on CT scans.
Symptomatic vasospasm was equally common among patients in whom either an early or a late lesion developed (33%; Table 2 ). Thus, the majority of ischemic lesions caused by DID were asymptomatic or produced very minor reversible symptoms.
Independent Risk Factors for Poor Outcome After SAH
On univariate analysis, several variables were associated with a poor outcome after SAH (Table 3) . On multivariate analysis (Model 1), after adjusting for clinical condition and the amount of subarachnoid and intracerebral blood, only the occurrence of an early ischemic lesion, patient age, admission hyperglycemia, and IVH were significant independent predictors of a poor outcome. The mean (Ϯ standard deviation) plasma D-dimer levels after surgery were 1250 Ϯ 1095 g/L for those with no infarct, 1522 Ϯ 1195 g/L for those with an early lesion, and 975 Ϯ 1152 g/L for those with a late lesion. When plasma Ddimer level was added to the multivariate analysis (Model 2), the significance of an early hypodense lesion somewhat diminished but still reached significance. The occurrence of an early lesion was a much more significant risk factor for poor outcome than was the appearance of a late lesion.
Other Findings
Of the patients with small lesions (Ͻ 20 mm in diameter) and those with larger lesions, 22 and 48%, respectively, had a poor outcome after SAH. The size distributions of early and late lesions were similar.
The presence and number of hypodense lesions on the follow-up CT scan and on the MR image similarly correlated with an impaired outcome as assessed using the GOS (GOS score compared with the number of lesions on CT: r s = 0.343, p Ͻ 0.001; GOS score compared with the number of lesions on MR imaging: r s = 0.363, p Ͻ 0.001). The number of lesions on CT and MR images showed nearly identical correlations (r s = 0.938, p Ͻ 0.001, data not shown). An increased rate of operations per surgeon did not significantly reduce the occurrence of hypodense lesions (r s = Ϫ0.13 to Ϫ0.06, p = 0.12-0.44) or improve outcome (r s = Ϫ0.033 to Ϫ0.084, p = 0.30-0.69).
Discussion
We report that SAH survivors with a new ischemic lesion on the first postoperative day have a multifold risk of a poor outcome as compared with survivors without a lesion. This risk is independent of several other prognostic factors and seems to be more important than the risk caused by vasospasm.
Study Design
Because we relied on CT and MR images obtained in survivors after SAH, our conclusions cannot necessarily be generalized to the whole population with SAH. Moreover, death after SAH is difficult to reduce because it is mainly influenced by factors difficult to address by treatment, such as severity of bleeding, early rebleeding, ICH, and poor condition on admission. However, the quality of life in survivors of SAH may be improved, especially in those in good condition after hemorrhage. A study focused on survivors and structured to determine the causes of an unexpectedly poor outcome in good-grade patients would be required to address this issue. Thus, we studied survivors of SAH rather than patients whose destiny was largely determined before admission. Our selection strategy also explains why a patient's condition on admission, previously shown to correlate with outcome after SAH, 7, 9 was not an independent risk factor of a poor outcome in the present study.
Computed Tomography and MR Imaging
For acute cerebral ischemia, MR imaging is traditionally considered superior to CT scanning in specificity and sensitivity. 3 Computed tomography scanning, as opposed to MR imaging, is widely available, easily repeatable, has a short study time, and is sensitive to new hemorrhage and hydrocephalus while being relatively insensitive to motion artifacts. In the present study, permanent ischemic lesions were almost equally visible on CT and MR images. Both CT and MR imaging results correlated strongly with clinical outcome, and both revealed as many or more lesions than most of the previous studies. 4, 5, 9, 10, 13, 14 Furthermore, the size of the ( lesions as revealed on CT and MR imaging was similar. Therefore, CT seems to be an acceptable method of detecting new, permanent ischemic lesions. Of course, perhaps MR imaging or diffusion-weighted CT can demonstrate even more ischemic lesions at earlier time points than did CT.
Early Compared With Late Ischemia
On the first postoperative day after treatment of a ruptured aneurysm, one half the permanent ischemic lesions were invisible on CT. Note, however, that the early lesions seemed to impair patient outcome much more than the later lesions. In fact, the late lesions seemed to occur mainly in those whose final clinical outcome remained relatively good. The origin of ischemic lesions visualized on CT scans more than 10 days after SAH most likely is delayed cerebral ischemia, which may be less harmful to patient outcome than early ischemia. This finding, at least in part, may be explained by the success of the current aggressive treatment of delayed vasospasm.
Impairment of cerebral blood circulation by activation of the coagulation system after SAH is an independent risk factor for a poor prognosis after SAH 12 and can be a major cause of early ischemia. Note, however, that the severity of bleeding, as assessed using clinical and radiological variables, did not explain the association between an early ischemic lesion and a poor outcome. Activation of the coagulation system as determined by plasma D-dimer levels was not significantly associated with the appearance of early or late hypodense lesions. Nevertheless, the strong correlation between early lesions and a poor outcome was weakened by adding the plasma D-dimer levels into the multivariate analysis, thus indicating that some of the early ischemia may be related to the fact that those patients are in a hypercoagulative state or at least that the hypercoagulative state may increase the risk from treatment.
Early ischemia results not only from severe initial bleeding and the subsequent impairment of cerebral circulation and activation of the coagulation system, but also from treatment complications, including angiographic complications and those related to permanent clipping of the parent or perforating artery or prolonged (Ͼ 10 minutes) temporary clipping. 13 The fact that these complications were more commonly related to open surgery than to coil embolization was considered to be the reason for the poorer outcome in surgically treated patients in the International Subarachnoid Aneurysm Trial. 16 Our findings also suggest that, although large lesions are more dangerous, small lesions are harmful as well. Moreover, the relatively greater danger from early lesions is not explained by their larger size, because the size distributions of early and late lesions were similar.
Possible Reasons for Dangers From Early Ischemia
An ischemic lesion on the first postoperative day was a much greater risk factor for poor outcome than the occurrence of later lesions compared with cases involving no lesions within 3 months after SAH. It is possible that by starting earlier, such ischemia is sustained for longer periods and has more harmful effects during the fragile stage when the brain is still vulnerable because of diminished cerebral blood flow and is thus more prone to secondary damage. Similarly, during the early phase of the disease, brain circulation has had insufficient time to adapt to the diminished blood flow, unlike in the later situation. Furthermore, early lesions may be caused by treatment complications more often than the late ones. These lesions are more likely than vasospasm to cause permanently damaged cerebral arteries and thus may be more difficult to overcome than vasospasm.
Rate of Ischemic Lesions
In the present study, we did not focus on clinical complications but on the rate of new, often small, and asymptomatic 19 hypodense lesions detected by an experienced neuroradiologist blinded to clinical data. The prevalence of early lesions has not been reported, meaning that no "generally accepted" rate exists.
The overall rate (65%) of new hypodense lesions on 3-month post-SAH CT and MR images and the outcome and rate of operative complications correlates well with recently published figures. 2, 6, 7 The rate of late (3.3 years on average) ischemic lesions on MR imaging among patients with SAH has been reported to be as high as 81%.
14 In a nicardipine study in 365 patients with SAH, the number of new ischemic lesions on follow-up CT was 58%. 5 In a newer study by Shimoda et al., 19 the rate of new ischemic lesions on MR images was 57%, even if the lesions developing during the first 3 days after SAH were not taken into account. In a magnesium sulfate in aneurysmal subarachnoid hemorrhage study, 21 the rate of new hypodense lesions was 45%, even if the CT was obtained only in symptomatic patients. Given that it is known that as many as 23% of the lesions are asymptomatic, 19 the total rate of new lesions in that study as well as in others is close to our numbers. Furthermore, when the number of new ischemic lesions possibly relating to complications of surgery or angiography is not reported and is excluded from analysis, the number of new hypodense lesions (39%) again is comparable to our results. 18 
Clinical Implications
The harmfulness of early ischemia underlines the crucial importance of avoiding treatment complications after SAH and thus means that choosing the best possible treatment option is vital. Waiting for the best option may be justified in some cases, such as when the treating neurosurgeon/neurointerventionist lacks the experience required. The relative harmfulness of early ischemia compared with late ischemia may also partly explain why it seems so difficult to improve the outcome in patients with SAH by treatments meant to improve vasospasm, that is, late ischemia.
Conclusions
An ischemic lesion on the first postoperative CT scan is a strong, independent risk factor for a poor prognosis after SAH and seems to be more harmful to clinical outcome than are lesions developing later. Routine postoperative CT examination may serve as a quality control tool in assessing the safety and method of treatment for a ruptured aneurysm.
